Click it and Unblock the Notifications
Just In
Don't Miss
-
Multibagger Energy Stock To Reward Shareholders With 3 Bonus Shares, Hits 52-Week High -
Main Hoon Saath Tere Launch Date, Cast: From Real To Reel, Karan Vohra Shares His Fatherhood Journey -
Royal Enfield Unveils Revolutionary Rentals & Tours Service: Check Out All Details Here -
Kavya Maran: All You Need To Know - Personal Life, Net Worth, Educational Background And Others -
Elon Musk’s X Is Launching a TV App Similar to YouTube for Watching Videos -
AICTE introduces career portal for 3 million students, offering fully-sponsored trip to Silicon Valley -
Heeramandi Screening: Alia Bhatt, Ananya Panday, Rashmika Mandanna And Others Serve Finest Ethnic Style! -
Escape to Kalimpong, Gangtok, and Darjeeling with IRCTC's Tour Package; Check Itinerary
AIIMS Delhi to start screening for clinical trials of Covaxin on children from today
New Delhi, Jue 06: After AIIMS Patna, AIIMS Delhi to start screening for clinical trials of the indigenous Bharat Biotech's COVID-19 vaccine Covaxin on children from tomorrow, ANI quoted as sources.
The trial will be conducted on 525 healthy volunteers and the vaccine will be given by intramuscular route in two doses at day 0 (the first day) and day 28, according to the Health Ministry.
Covaxin, which has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is being used on adults in India's ongoing COVID-19 vaccination drive.
On May 13, the Drugs Controller General of India (DCGI) had given nod to phase-2/3 trials on children aging 2-18-year-olds.
It should be noted that India started the world's largest vaccination drive on January 16 this year in a phased manner with healthcare workers (HCWs) getting inoculated first.
India has three COVID-19 vaccine - Bharat Biotech's Covaxin, Serum Institute's Covishield and Russia's Sputnik V. Covaxin and Covishield are being manufactured in India.
